Welters Anthony
WELTERS ANTHONY, DIR, reported an open-market or private sale at GILEAD SCIENCES, INC. involving 3118.000000 shares for an estimated $462432.45. Reported holdings after the transaction were 17494.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 26, 2026
- Filing date
- Aug 27, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 20,612 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
GILD price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001213307-26-000005 Common Stock
- Transaction date
- Aug 26, 2026 Filed Aug 27, 2026, 10:44 PM · 1d delay
- Shares
- 3,118 sh $148.31 per share
- Estimated value
- -$462k Computed from shares × price
- Holdings after
- 17,494 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.
- F2
Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the iss…
- F3
Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the iss…
- F4
Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the iss…
- F5
Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the iss…
- F6
100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020.
- F7
25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on Oc…
0 other transactions
0 recent txs